Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Neola Medical ABOSTO:NEOLA +7.21%29 PB Ratio is 0.63 as of Aug. 07, 2026, which is 48% below its 10-year median of 1.22. GuruFocus rates OSTO:NEOLA with a GF Score™ of 29/100. The stock has 1 warning sign investors should review. Among 787 Medical Devices & Instruments companies, Neola Medical AB ranks better than 90.09% on this metric.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2026-08-07), Neola Medical AB's share price is kr0.595. Neola Medical AB's Book Value per Share for the quarter that ended in Dec. 2025 was kr0.94. Hence, Neola Medical AB's PB Ratio of today is 0.63.
The historical rank and industry rank for Neola Medical AB's PB Ratio or its related term are showing as below:
OSTO:NEOLA'
s PB Ratio Range Over the Past 10 Years
Min: 0.4 Med: 1.22 Max: 2.61
Current: 0.64
During the past 8 years, Neola Medical AB's highest PB Ratio was 2.61. The lowest was 0.40. And the median was 1.22.
OSTO:NEOLA's PB Ratio is ranked better than 90.09% of 787
companies
in the Medical Devices & Instruments industry
Industry Median: 2.14
vs OSTO:NEOLA: 0.64
During the past 12 months, Neola Medical AB's average Book Value Per Share Growth Rate was -1.20% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was -7.10% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was -14.00% per year.
During the past 8 years, the highest 3-Year average Book Value Per Share Growth Rate of Neola Medical AB was 6.70% per year. The lowest was -19.90% per year. And the median was -7.10% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Neola Medical AB PB Ratio Related Terms
Neola Medical AB PB Ratio Historical Data
* Premium members only.
The historical data trend for Neola Medical AB's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Neola Medical AB's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Neola Medical AB PB Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Neola Medical AB's PB Ratio distribution charts can be found below:
* The bar in red indicates where Neola Medical AB's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Neola Medical AB (OSTO:NEOLA) has a PB Ratio of 0.63 as of Aug. 07, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Neola Medical AB and its competitors. This is 48% below median its historical median of 1.22. Over the past decade, Neola Medical AB's PB Ratio has ranged from 0.40 to 2.61. According to the industry distribution chart, Neola Medical AB ranks #78 out of 787 companies in the Medical Devices & Instruments industry, placing it in the top 9.9%.
Is Neola Medical AB's PB Ratio too high?
Neola Medical AB's current PB Ratio of 0.63 is 48% below median its 10-year median of 1.22. Over the past 10 years, this metric has ranged from a low of 0.40 to a high of 2.61. The Medical Devices & Instruments industry median PB Ratio is 2.14. Neola Medical AB's value of 0.63 is 70.6% below this industry median. Based on the distribution chart, Neola Medical AB ranks #78 out of 787 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Neola Medical AB has a GF Score™ of 29/100, reflecting its overall financial health beyond just this single metric.
How does Neola Medical AB's PB Ratio compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Neola Medical AB ranks #78 out of 787 companies for PB Ratio. This places Neola Medical AB in the top 10% of its industry — outperforming the majority of peers. The industry median PB Ratio is 2.14. Neola Medical AB's value of 0.63 is 70.6% below this benchmark. Historically, Neola Medical AB's own PB Ratio has ranged from 0.40 to 2.61 over the past decade. While the company's 10-year median is 1.22 vs. the industry median of 2.14, Neola Medical AB has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Medical Devices & Instruments company?
The median PB Ratio among Medical Devices & Instruments companies is 2.14, based on 787 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Neola Medical AB's current PB Ratio of 0.63 is 70.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Neola Medical AB and its competitors. For the Medical Devices & Instruments industry, the median PB Ratio is 2.14 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Neola Medical AB's current PB Ratio is 0.63, which is 48% below median its own 10-year median of 1.22. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Neola Medical AB stock overvalued right now?
Neola Medical AB (OSTO:NEOLA) has a current PB Ratio of 0.63. The current PB Ratio is 0.63, which is 48% below median its 10-year median of 1.22 and 70.6% below the Medical Devices & Instruments industry median of 2.14. Neola Medical AB's overall GF Score™ is 29/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Neola Medical AB (OSTO:NEOLA), the current PB Ratio is 0.63 as of Aug. 07, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Neola Medical AB is revolutionizing neonatal intensive care with NEOLA, a medical device that can offer continuous lung monitoring and real-time alerts of life-threatening complications using a technology that measures lung volume changes and oxygen gas concentration. NEOLA has the potential to provide care, fewer days in intensive care, and healthier lives for preterm born infants. The company is building on a historic Swedish legacy of medical technology innovation and invaluable contributions to health care.
29GF Score
Get the complete analysis for OSTO:NEOLA
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OSTO:NEOLA has been successfully added to your 
